Biography and Research Information
OverviewAI-generated summary
Matthew Parke's research has focused on the molecular mechanisms of cancer, specifically investigating novel tumor classifications and the genetic underpinnings of specific sarcoma subtypes. His work includes the identification and characterization of POU2AF3-rearranged sarcomas, a newly defined tumor type distinguished by gene fusions involving EWSR1 or FUS with a gene previously identified as COLCA2. Parke has also contributed to the understanding of complex infectious disease presentations in immunocompromised individuals, detailing a case of concomitant disseminated histoplasmosis and atypical mycobacterial infection in a patient with advanced HIV infection. His scholarly contributions are reflected in a h-index of 1, with two publications and 13 total citations.
Metrics
- h-index: 1
- Publications: 2
- Citations: 13
Selected Publications
-
Concomitant and disseminated histoplasma and atypical mycobacterial infection complicating <scp>HIV</scp> infection (2023)
-
<scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp> (2023)
Collaboration Network
Top Collaborators
Matthew Hiemenz
PHG Foundation (GB)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Jaspreet Kaur
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Zheng Kuang
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Richard S.P. Huang
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Lukas Harries
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Dana Metzger
PHG Foundation (GB)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Kelsie Schiavone
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Sherri Z. Millis
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Douglas I. Lin
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Mirna Lechpammer
PHG Foundation (GB)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Brennan Decker
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Douglas A. Mata
PHG Foundation (GB)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Abhinav V. Reddy
Foundation Medicine (United States)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Eun Young Lee
University of Kentucky (US)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Xiaoyan Cui
The Ohio State University Wexner Medical Center (US)
1 shared publication
- <scp>POU2AF3</scp>‐rearranged sarcomas: A novel tumor defined by fusions of <scp>EWSR1</scp> or <scp>FUS</scp> to a gene formerly designated <scp>COLCA2</scp>
Similar Researchers
Based on overlapping research topics
Lu, Yong-Chen
University of Arkansas for Medical Sciences
Genomics and Rare Diseases
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Jennifer A. Rumpel
University of Arkansas for Medical Sciences
Genomics and Rare Diseases
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Logan Meurer
Arkansas State University
Molecular Biology Techniques and Applications
Microbial infections and disease research
Cancer-related molecular mechanisms research
Elizmary Cyril
University of Arkansas for Medical Sciences
Molecular Biology Techniques and Applications
Microbial infections and disease research
Cancer-related molecular mechanisms research
PhD Feifei Wei
University of Arkansas for Medical Sciences
Molecular Biology Techniques and Applications
Microbial infections and disease research
Cancer-related molecular mechanisms research
M.D.Ph.D. Stephan B Melnyk
University of Arkansas for Medical Sciences
Molecular Biology Techniques and Applications
Microbial infections and disease research
Cancer-related molecular mechanisms research